The advancement of technology, a robust regulatory framework and rising requirements for affordable healthcare have driven the growth of India's pharmaceutical startup ecosystem. The country that is so famous for being the generic drug's powerhouse is now host to a multitude of startups that are innovating in drug discovery, biotech, digital health and affordable medicine development.

Integration of Artificial Intelligence (AI), Machine Learning (ML) is a key driver of innovation. These technologies are now being used by startups that are using these technologies to accelerate drug discovery by mining large data sets, identifying potential drug candidates, and predicting drug effectiveness. Of course, this technology also plays an essential role in precision medicine, so treatments can be fashioned after individual genetic profiles, improving drug efficacy while reducing side effects.

Biotech startups are looking to biologics, biosimilars and gene therapies for advanced treatments of diseases like cancer and autoimmune disorders. A broader population is being made able to access cutting edge treatments through these companies who are offering affordable alternatives to expensive branded biologics. In addition, the development of vaccines and novel therapies is led by biotechnology in India that is helping the country become a major player in global healthcare.

India’s pharmaceutical industry...